CN Patent

CN105473617A — 针对人csf-1r的抗体和针对人pd-l1的抗体的组合疗法

Assigned to F Hoffmann La Roche AG · Expires 2016-04-06 · 10y expired

What this patent protects

本发明涉及结合人CSF-1R的特定抗体与结合人PD-L1的特定抗体的组合疗法。

USPTO Abstract

本发明涉及结合人CSF-1R的特定抗体与结合人PD-L1的特定抗体的组合疗法。

Drugs covered by this patent

Patent Metadata

Patent number
CN105473617A
Jurisdiction
CN
Classification
—
Expires
2016-04-06
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.